Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Budget Health Benefits topic
No spam. Unsubscribe anytime.
Health‑benefits costs likely to drive Hopewell Valley’s 2026 budget, consultant warns
Summary
A benefits consultant told the board post‑COVID utilization, more high‑cost claims and a surge in GLP‑1 prescription costs (about 30% of pharmacy spend) are inflating health‑care costs; the district's self‑insured status provides some protection but officials warned of continued volatility.
The board received a briefing on factors expected to push the Hopewell Valley school district’s health‑benefit costs higher in 2026.
Robert Maguire of Integrity Consulting Group told trustees that post‑COVID catch‑up care has led to higher utilization and more frequent high‑cost claims; he said the number of members with very large claims has roughly doubled in his book of business. Maguire also highlighted growing out‑of‑network costs and an independent dispute resolution process that he said now often favors providers.
On pharmacy costs, Maguire specifically called out the rapid growth of GLP‑1 medications (examples cited: Ozempic, Wegovy, Zepbound) and said they now account for "about 30% of your total prescription cost" for some clients. He warned that a forthcoming pill form could further increase demand and cost.
Maguire contrasted the district's self‑insured status with the state educators' plan, which he said has recently posted sharp premium increases (he cited the state plan seeing roughly 25% increase on medical and higher jumps on prescriptions). Board members and administrators noted reserves and IBNR (incurred but not reported) accounting as cushions but said the district must plan conservatively as negotiations and state policy (Chapter 44 / the Garden State plan rules) limit options for shifting costs via bargaining for new employees until a state review is completed in 2027.
Administrators said they will begin market surveys in January and continue to monitor claims and pharmacy trends while preparing the 2026 budget.
